These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 27693265)

  • 1. Differential Effects of Cyproterone Acetate vs Spironolactone on Serum High-Density Lipoprotein and Prolactin Concentrations in the Hormonal Treatment of Transgender Women.
    Fung R; Hellstern-Layefsky M; Tastenhoye C; Lega I; Steele L
    J Sex Med; 2016 Nov; 13(11):1765-1772. PubMed ID: 27693265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Androgenic Effects Comparison Between Cyproterone Acetate and Spironolactone in Transgender Women: A Randomized Controlled Trial.
    Burinkul S; Panyakhamlerd K; Suwan A; Tuntiviriyapun P; Wainipitapong S
    J Sex Med; 2021 Jul; 18(7):1299-1307. PubMed ID: 34274044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concerning the Article by Fung et al, Titled "Differential Effects of Cyproterone Acetate vs Spironolactone on Serum High-Density Lipoprotein and Prolactin Concentrations in the Hormonal Treatment of Transgender Women".
    Defreyne J; T'Sjoen G
    J Sex Med; 2017 Jan; 14(1):172-173. PubMed ID: 28065354
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-Dose Cyproterone Acetate Treatment for Transgender Women.
    Even Zohar N; Sofer Y; Yaish I; Serebro M; Tordjman K; Greenman Y
    J Sex Med; 2021 Jul; 18(7):1292-1298. PubMed ID: 34176757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to "Letter to the Editor Concerning the Paper by Fung et al titled 'Differential Effects of Cyproterone Acetate vs Spironolactone on Serum High-Density Lipoprotein and Prolactin Concentrations in the Hormonal Treatment of Transgender Women".
    Fung R; Lega I
    J Sex Med; 2017 Jan; 14(1):173-174. PubMed ID: 28065355
    [No Abstract]   [Full Text] [Related]  

  • 6. Transient Elevated Serum Prolactin in Trans Women Is Caused by Cyproterone Acetate Treatment.
    Defreyne J; Nota N; Pereira C; Schreiner T; Fisher AD; den Heijer M; T'Sjoen G
    LGBT Health; 2017 Oct; 4(5):328-336. PubMed ID: 28880825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin levels during short- and long-term cross-sex hormone treatment: an observational study in transgender persons.
    Nota NM; Dekker MJHJ; Klaver M; Wiepjes CM; van Trotsenburg MA; Heijboer AC; den Heijer M
    Andrologia; 2017 Aug; 49(6):. PubMed ID: 27561756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of sequential cyproterone acetate/estrogen versus spironolactone/oral contraceptive in the treatment of hirsutism.
    O'Brien RC; Cooper ME; Murray RM; Seeman E; Thomas AK; Jerums G
    J Clin Endocrinol Metab; 1991 May; 72(5):1008-13. PubMed ID: 1827125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyproterone acetate or drospirenone containing combined oral contraceptives plus spironolactone or cyproterone acetate for hirsutism: randomized comparison of three regimens.
    Kelekci KH; Kelekci S; Yengel I; Gul S; Yilmaz B
    J Dermatolog Treat; 2012 Jun; 23(3):177-83. PubMed ID: 21254871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Distinct Antiandrogen Exposures on the Plasma Metabolome in Feminizing Gender-affirming Hormone Therapy.
    Shepherd R; Angus LM; Mansell T; Arman B; Kim BW; Lange K; Burgner D; Kerr JA; Pang K; Zajac JD; Saffery R; Cheung A; Novakovic B
    J Clin Endocrinol Metab; 2024 Oct; 109(11):2857-2871. PubMed ID: 38609170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consecutive Cyproterone Acetate and Estradiol Treatment in Late-Pubertal Transgender Female Adolescents.
    Tack LJW; Heyse R; Craen M; Dhondt K; Bossche HV; Laridaen J; Cools M
    J Sex Med; 2017 May; 14(5):747-757. PubMed ID: 28499525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
    Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
    Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of antiandrogens and feminization in transgender women.
    Angus LM; Nolan BJ; Zajac JD; Cheung AS
    Clin Endocrinol (Oxf); 2021 May; 94(5):743-752. PubMed ID: 32926454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Endocrine and Metabolic Effects of Testosterone Suppressive Agents in Transgender Women.
    Sofer Y; Yaish I; Yaron M; Bach MY; Stern N; Greenman Y
    Endocr Pract; 2020 Aug; 26(8):883-890. PubMed ID: 33471679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of desogestrel/ethinyl estradiol plus spironolactone versus cyproterone acetate/ethinyl estradiol in the treatment of polycystic ovary syndrome: a randomized controlled trial.
    Leelaphiwat S; Jongwutiwes T; Lertvikool S; Tabcharoen C; Sukprasert M; Rattanasiri S; Weerakiet S
    J Obstet Gynaecol Res; 2015 Mar; 41(3):402-10. PubMed ID: 25319761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study.
    Kuijpers SME; Wiepjes CM; Conemans EB; Fisher AD; T'Sjoen G; den Heijer M
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e3936-e3945. PubMed ID: 34125226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TESTOSTERONE LEVELS ACHIEVED BY MEDICALLY TREATED TRANSGENDER WOMEN IN A UNITED STATES ENDOCRINOLOGY CLINIC COHORT.
    Liang JJ; Jolly D; Chan KJ; Safer JD
    Endocr Pract; 2018 Feb; 24(2):135-142. PubMed ID: 29144822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of 5-year administration of cyproterone acetate or leuprolide acetate in combination with estradiol in transwomen.
    Gava G; Mancini I; Alvisi S; Seracchioli R; Meriggiola MC
    Eur J Endocrinol; 2020 Dec; 183(6):561-569. PubMed ID: 33055297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiandrogens and hirsutism.
    Biffignandi P; Molinatti GM
    Horm Res; 1987; 28(2-4):242-9. PubMed ID: 2969862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyproterone acetate vs leuprolide acetate in combination with transdermal oestradiol in transwomen: a comparison of safety and effectiveness.
    Gava G; Cerpolini S; Martelli V; Battista G; Seracchioli R; Meriggiola MC
    Clin Endocrinol (Oxf); 2016 Aug; 85(2):239-46. PubMed ID: 26932202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.